background
viral
protein
r
vpr
protein
human
immunodefici
viru
variou
biolog
function
shown
present
blood
patient
howev
remain
unclear
whether
circul
vpr
patient
blood
biolog
activ
examin
activ
blood
vpr
use
assay
system
retrotransposit
long
interspers
detect
also
investig
vivo
effect
recombin
vpr
rvpr
administr
transgen
mice
harbor
human
transgen
mice
base
data
discuss
involv
blood
vpr
clinic
symptom
acquir
immunodefici
syndrom
aid
result
first
discov
rvpr
activ
induct
biochem
analys
reveal
rvprinduc
depend
aryl
hydrocarbon
receptor
mitogenactiv
protein
kinas
ccaat
enhancerbind
protein
use
sensit
assay
system
show
blood
sampl
patient
examin
posit
induct
note
activ
block
monoclon
antibodi
specif
vpr
moreov
reproduc
induc
variou
organ
includ
kidney
rvpr
administ
mice
conclus
blood
vpr
biolog
activ
suggest
monitor
worthwhil
clarif
role
vpr
pathogenesi
aid
first
report
demonstr
solubl
factor
patient
blood
activ
activ
impli
involv
develop
human
diseas
viral
protein
r
vpr
accessori
gene
human
immunodefici
viru
encod
virionassoci
nuclear
protein
kda
vpr
varieti
biolog
function
includ
cell
cycl
abnorm
g
phase
apoptosi
cell
neuron
cell
recent
review
see
ref
notabl
shown
vpr
present
blood
patient
previous
report
blood
sampl
patient
examin
posit
vpr
blood
vpr
detect
patient
high
titr
interestingli
also
detect
patient
low
viral
titr
hand
purifi
recombin
vpr
protein
rvpr
function
transact
factor
rvpr
activ
viral
replic
latent
infect
cell
increas
product
monocyt
analys
reveal
rvprinduc
product
depend
mitogenactiv
protein
kinas
mapk
ccaatenhancerbind
protein
observ
suggest
blood
vpr
could
induc
variou
clinic
symptom
remain
unclear
whether
blood
vpr
biolog
activ
long
interspers
alu
major
endogen
retroel
account
human
genom
respect
autonom
retroel
retrotranspos
also
retroel
alu
sva
short
interspers
elementvari
number
tandem
repeatalu
sinevntralu
intriguingli
singl
human
cell
contain
copi
compet
retrotransposit
earli
embryogenesi
incident
disrupt
gene
structur
lead
develop
inborn
error
note
approxim
type
inherit
diseas
identifi
sporad
case
caus
mutagen
rtp
alu
although
studi
focus
earli
embryogenesi
recent
line
evid
suggest
also
induc
somat
cell
tumor
epithelialcel
origin
hepatoma
de
novo
insert
detect
vicin
tumor
suppressor
gene
suggest
activ
involv
carcinogenesi
alter
cellular
properti
caus
variou
genet
altern
includ
gene
delet
dna
damag
apoptosi
immun
respons
deregul
somat
cell
like
function
trigger
variou
diseas
present
evid
vpr
activ
induct
demonstr
blood
sampl
patient
posit
vprinduc
interestingli
rvpr
reproduc
induc
variou
organ
includ
kidney
administ
mice
harbor
human
transgen
mice
clinic
nephropathi
hivan
mainli
observ
among
africanamerican
endstag
renal
defici
found
without
appar
correl
viral
load
view
report
vpr
candid
molecul
respons
hivan
propos
monitor
blood
level
vpr
import
determin
involv
pathogenesi
hivan
initi
perform
coloni
format
assay
use
purifi
rvpr
r
figur
b
human
hepatoma
cell
treat
rvpr
occur
approxim
cell
figur
p
rvpr
caus
appar
cytotox
addit
file
figur
activ
rvpr
also
confirm
pcrbase
assay
use
signal
intens
bp
band
correspond
product
increas
treatment
rvpr
figur
lower
panel
rational
pcrbase
assay
lane
quantit
pcr
qpcr
analysi
also
carri
use
taqman
probe
design
detect
junction
point
two
exon
egfp
gene
figur
bottom
see
also
addit
file
figur
standard
qpcr
curv
data
reveal
rvpr
significantli
increas
frequenc
figur
p
notabl
rvprinduc
complet
block
monoclon
antibodi
mab
vpr
figur
lane
irrelev
mab
spike
protein
sever
acut
respiratori
syndrom
coronaviru
figur
lane
sar
vprinduc
also
observ
cell
activ
ngml
rvpr
detect
figur
lane
addit
file
figur
take
advantag
high
sensit
pcrbase
assay
perform
use
cell
explor
activ
blood
sampl
patient
among
sampl
analyz
pcr
assay
posit
induct
figur
upper
panel
patient
clinic
inform
summar
addit
file
tabl
notabl
activ
select
block
indic
activ
patient
attribut
vpr
figur
c
interestingli
vprinduc
detect
patient
low
titr
figur
addit
file
tabl
confirm
carri
immunoprecipit
follow
western
blot
analysi
ipwb
analysi
success
detect
vpr
one
two
blood
sampl
posit
addit
file
figur
arrowhead
estim
concentr
blood
vpr
compar
signal
standard
rvpr
would
approxim
ngml
addit
file
figur
contrast
could
detect
vpr
anoth
sampl
determin
effect
rvpr
vivo
next
investig
administr
rvpr
mice
figur
solid
line
shown
figur
detect
organ
includ
lymph
node
liver
thymu
spleen
upon
intraperiton
administr
ng
rvpr
three
time
everi
day
addit
file
tabl
interestingli
qpcr
analysi
detect
kidney
six
intraven
administr
ng
rvpr
figur
demonstr
rvprinduc
depend
revers
transcriptas
activ
first
carri
vitro
experi
examin
whether
rvprinduc
block
nucleotid
analogu
inhibitor
revers
transcriptas
rti
shown
figur
stavudin
tenofovir
inhibit
rvpr
activ
induct
lane
lamivudin
azidothymidin
azt
lane
inhibitori
effect
rvprinduc
potent
compound
could
effect
block
induct
concentr
addit
file
figur
next
investig
effect
stavudin
analogu
specif
activ
rti
fewer
side
effect
shown
figur
administ
intraperiton
h
intraven
administr
ng
rvpr
effici
attenu
compar
lane
qpcr
analysi
also
clearli
show
inhibitori
effect
figur
immunohistochem
analysi
use
success
detect
cell
posit
induct
singl
inject
ng
vpr
figur
intriguingli
occur
frequenc
sever
cell
per
cell
six
administr
ng
rvpr
figur
p
coadministr
significantli
block
induc
repetit
inject
ng
rvpr
figur
column
consist
result
obtain
hematoxylineosin
stain
dual
stain
marker
proxim
renal
tubular
cell
detect
rvprinduc
renal
tubular
epitheli
cell
rtec
figur
also
investig
methyl
statu
cpg
rvprtreat
kidney
analysi
cobra
method
method
quantifi
cpg
methyl
detect
appar
chang
methyl
statu
cpg
six
administr
ng
rvpr
addit
file
figur
rvprinduc
depend
cellular
cascad
previous
report
variou
environment
compound
induc
manner
depend
aryl
hydrocarbon
receptor
ahr
shown
associ
cellular
molecul
via
lxxll
motif
counterpart
molecul
amino
acid
denot
singl
letter
interestingli
vpr
contain
mab
vpr
block
activ
serum
sampl
serum
sampl
treat
ng
v
sarsmab
serum
sampl
healthi
volunt
also
includ
healthi
e
j
ri
rel
intens
c
effect
activ
ri
shown
figur
plot
compar
treatment
mab
sar
v
consider
attenu
activ
patient
blood
detect
vprinduc
patient
lower
viral
titr
without
activ
accord
presenc
activ
blood
patient
separ
two
group
viral
load
patient
plot
blood
sampl
two
patient
group
subject
ipwb
analysi
vpr
detect
one
patient
addit
file
figur
vpr
detect
sampl
patient
posit
two
patient
neg
activ
vpr
patient
lqqll
motif
amino
acid
function
sequenc
motif
bind
host
cellular
protein
includ
acetyl
transferas
base
observ
hypothes
ahr
function
cellular
factor
respons
rvprinduc
prove
first
assess
effect
mnf
ahr
inhibitor
observ
mnf
complet
block
rvprinduc
addit
file
figur
moreov
downregul
endogen
ahr
express
ahr
sirna
accompani
reduc
rvprinduc
see
figur
lane
repres
result
experi
use
two
differ
ahr
sirna
see
also
addit
file
figur
b
data
obtain
use
anoth
ahr
sirna
contrast
downregul
sirna
figur
attenu
figur
lane
addit
file
figur
lane
ahr
form
heterodim
ahr
complex
involv
induct
mrna
express
respons
environment
pollut
ahr
sirna
block
induct
mrna
express
carbazol
ficz
tryptophan
photoproduct
addit
file
figur
indic
sirna
effici
inhibit
function
properti
ahr
complex
suggest
rvprinduc
depend
ahr
determin
import
lxxll
motif
vpr
induct
investig
activ
vpr
mutant
contain
aqqaa
instead
lqqll
la
mutant
lam
figur
first
studi
forc
express
wildtyp
vpr
wt
vpr
la
mutant
reveal
mutant
activ
induct
figur
figur
done
measur
qpcr
analysi
detect
associ
wtvpr
ahr
figur
lane
less
interact
la
mutant
ahr
figur
lane
data
suggest
vprinduc
depend
molecular
interact
ahr
via
lxxll
motif
vpr
identifi
addit
cellular
factor
involv
rvprinduc
investig
involv
mapk
previou
work
reveal
vpr
induc
product
via
activ
first
qpcr
analysi
reveal
mapk
inhibitor
attenu
rvprinduc
basal
level
observ
treatment
control
buffer
figur
see
also
addit
file
figur
repres
qpcr
data
data
indic
test
compound
inhibit
upregul
rvpr
previou
studi
show
import
understand
cellular
respons
exogen
appli
rvpr
impli
molecul
also
involv
induct
immunohistochem
analysi
use
perform
mice
administ
rvpr
intraperiton
left
four
panel
ng
rvpr
intraven
right
panel
upper
panel
buffer
control
lower
panel
rvpr
green
egfpposit
cell
blue
hoechst
stain
histolog
stain
also
depict
bar
arrow
egfpposit
cell
b
induct
kidney
result
six
time
intraven
inject
ng
rvpr
shown
column
buffer
control
column
rvpr
sampl
three
differ
slice
prepar
immunohistochem
analysi
done
obtain
number
egfpposit
cell
subject
statist
analysi
p
c
rvpr
induc
block
effect
induct
rvpr
examin
use
mice
mice
intraven
inject
ng
rvpr
six
time
examin
effect
compound
intraperiton
inject
h
prior
inject
rvpr
inhibitori
effect
statist
signific
p
column
buffer
column
ng
rvpr
column
ng
rvpr
rvpr
induc
proxim
rtec
doubl
stain
perform
bar
mice
intraven
inject
ng
rvpr
six
time
experi
egfpposit
cell
detect
control
kidney
mous
inject
buffer
rvpr
confirm
focus
effect
sirna
rvpr
activ
shown
figur
transfect
sirna
downregul
endogen
protein
level
attenu
rvprinduc
figur
lane
see
also
addit
file
figur
data
obtain
use
anoth
sirna
target
mrna
use
experi
shown
figur
contrast
sirna
creb
cjun
attenu
rvprinduc
figur
although
sirna
effici
downregul
endogen
protein
express
addit
file
figur
g
one
possibl
reason
mapk
inhibitor
specif
target
molecul
chromatin
recruit
induc
rvpr
depend
ahr
encod
two
protein
open
read
kda
respect
present
cytoplasm
ribonucleoprotein
complex
cytoplasm
stress
granul
moreov
initi
targetprim
revers
transcript
within
genom
function
nucleic
acid
chaperon
observ
suggest
recruit
chromatin
fraction
respons
rvpr
treatment
demonstr
chromatin
recruit
transfect
plasmid
dna
encod
cell
carri
wb
analysi
chromatin
fraction
transfect
cell
treatment
rvpr
rvprinduc
chromatin
recruit
block
mapk
inhibitor
examin
figur
lane
ahr
sirna
figur
lane
see
also
addit
file
figur
result
independ
experi
perform
use
differ
ahr
sirna
show
ahr
form
complex
transfect
plasmid
dna
encod
chimer
protein
egfp
cell
perform
ipwb
analysi
ip
use
follow
wb
analysi
use
reveal
ahr
associ
figur
lane
revers
experi
ip
use
follow
wb
use
confirm
format
complex
figur
lane
interact
ahr
also
detect
cell
protein
express
exogen
addit
file
figur
previous
report
ficz
potent
activ
activ
depend
ahr
determin
function
link
perform
ipwb
analysi
transfect
cell
detect
extract
cell
treat
ficz
recov
use
figur
upper
panel
lane
contrast
recov
extract
cell
treat
rvpr
use
figur
upper
panel
lane
consist
result
obtain
revers
experi
wb
use
perform
sampl
recov
ip
use
figur
lower
panel
case
cell
extract
obtain
ficz
treatment
yield
posit
signal
figur
lower
panel
lane
data
suggest
associ
induc
exogen
ficz
rvpr
rvprinduc
depend
cellular
cascad
found
vpr
viral
protein
activ
induct
experi
use
mnf
sirna
target
ahr
mrna
mapk
inhibitor
reveal
rvprinduc
depend
cellular
cascad
figur
confirm
vitro
experi
rvpr
increas
express
mrna
splice
effici
immatur
egfp
transcript
deriv
report
construct
addit
file
figur
moreov
appar
chang
cpg
methyl
statu
observ
exogen
gene
kidney
mice
treat
rvpr
addit
file
figur
data
suggest
rvprinduc
control
posttranscript
level
although
propos
influenc
transcript
level
methyl
statu
addit
la
mutant
investig
activ
vpr
mutant
lack
ctermin
amino
acid
pcrbase
assay
reveal
mutant
activ
induct
addit
file
figur
shown
vpr
affin
nucleic
acid
attribut
basic
moieti
ctermin
region
vpr
exclud
possibl
induct
ahrdepend
vpr
depend
bind
nucleic
acid
investig
interact
vpr
ahr
nucleas
treatment
ipwb
analysi
combin
treatment
benzonas
nucleas
degrad
dna
rna
reveal
interact
reduc
addit
file
figur
addit
ahr
constitut
form
complex
interact
also
resist
nucleas
treatment
addit
file
figur
moreov
rvpr
trigger
chromatin
recruit
ahrdepend
manner
figur
taken
togeth
data
suggest
vpr
function
ahr
ligand
activ
cellular
cascad
induct
detect
activ
blood
patient
patient
posit
induct
figur
activ
six
patient
select
block
mab
vpr
figur
interestingli
previous
examin
blood
vpr
ipwb
analysi
detect
vpr
blood
sampl
patient
interestingli
posit
frequenc
observ
two
set
experi
compar
greater
number
sampl
need
conclud
blood
vpr
exclus
biolog
activ
although
report
antibodi
vpr
present
patient
blood
impli
vpr
activ
would
block
autoantibodi
current
experi
prove
blood
vpr
activ
induct
alter
cellular
properti
induc
dna
damag
apoptosi
tempt
specul
blood
vpr
modifi
clinic
outcom
aid
patient
consist
previou
observ
vpr
protein
detect
blood
sampl
patient
low
viral
titr
detect
vprinduc
sampl
patient
low
viral
titr
shown
figur
activ
detect
blood
sampl
ipwb
figur
conduct
chr
chromatin
fraction
cyt
cytoplasm
fraction
wce
wholecel
extract
b
buffer
v
rvpr
see
also
addit
file
figur
show
result
independ
experi
done
use
differ
ahr
sirna
c
associ
ahr
cell
transfect
construct
express
chimer
protein
egfp
flagtag
egfp
pflagegfp
ipwb
perform
use
follow
wb
use
lane
revers
experi
ip
use
perform
follow
wb
use
lane
rvpr
induc
associ
cell
transfect
pflagegfp
fe
lane
lane
treatment
cell
rvpr
lane
ficz
lane
ip
follow
wb
perform
use
respect
upper
panel
revers
experi
ip
use
follow
wb
use
perform
lower
panel
dmso
f
ficz
nm
v
rvpr
ngml
input
fraction
recov
use
prote
bead
analysi
success
detect
vpr
signal
addit
file
tabl
addit
file
figur
intriguingli
howev
viral
titr
patient
copiesml
figur
close
diamond
addit
file
tabl
strike
contrast
viral
titr
blood
sampl
patient
copiesml
appar
activ
detect
although
remain
complet
unknown
vpr
present
patient
low
viral
titr
one
possibl
explan
would
vpr
secret
blood
latent
foci
patient
vitro
experi
support
notion
vpr
excret
infect
cell
function
solubl
protein
bystand
effect
repeat
intraven
administr
ng
rvpr
dose
compar
patient
blood
level
induc
vivo
figur
observ
administr
rvpr
induc
variou
organ
lymph
node
spleen
addit
found
vpr
also
induc
kidney
figur
addit
file
tabl
notabl
even
singl
inject
ng
rvpr
tail
vein
induc
kidney
figur
right
panel
suggest
kidney
target
organ
vprinduc
immunohistochem
analysi
show
vpr
induc
rtec
especi
proxim
rtec
figur
previous
report
vpr
nef
candid
mediat
hivan
forc
express
viral
gene
mous
podocyt
result
proteinuria
glomerular
diseas
although
propos
renal
dysfunct
direct
effect
primari
infect
rtec
remain
investig
whether
repeat
administr
rvpr
caus
renal
insuffici
hivan
develop
mostli
peopl
african
descent
show
strong
influenc
genet
trait
howev
mechan
remain
complet
unknown
importantli
hivan
appar
correl
viral
load
intriguingli
propos
kidney
latent
reservoir
base
observ
plausibl
bloodcircul
vpr
vpr
secret
local
latent
reservoir
kidney
exampl
attack
rtec
prove
studi
requir
determin
whether
kidney
organ
vpr
constitut
secret
addit
clinic
relev
pathogenesi
find
gener
impact
involv
human
diseas
analysi
tumor
use
secondgener
sequenc
technolog
de
novo
insert
detect
vicin
tumor
suppressor
gene
suggest
insert
activ
involv
carcinogenesi
addit
shown
deregul
posit
link
develop
autoimmun
diseas
although
line
evid
reveal
induc
somat
cell
involv
develop
human
diseas
remain
unclear
induc
somat
cell
previous
report
pyridin
phip
foodborn
carcinogen
induc
mous
mammari
gland
target
organ
carcinogenesi
administ
oral
mice
given
phip
present
broil
meat
detect
human
breast
milk
plausibl
human
suscept
induct
environment
factor
studi
requir
demonstr
activ
patholog
condit
enabl
role
diseas
develop
specifi
six
blood
sampl
patient
examin
posit
vprinduc
activ
detect
blood
sampl
low
viral
titr
monitor
circul
vpr
relat
clinic
outcom
import
clarifi
role
vpr
aid
symptom
present
studi
first
show
activ
present
vivo
shed
light
possibl
involv
human
diseas
research
import
detect
activ
patholog
condit
obtain
riken
bioresourc
centr
cell
bank
cultur
dulbecco
modifi
eagl
medium
supplement
fetal
calf
serum
sigmaaldrich
st
loui
mi
usa
transfect
effici
respect
determin
fluorescenceactiv
cell
sort
fac
day
transfect
plasmid
dna
encod
enhanc
green
fluoresc
protein
egfp
data
shown
mnf
kindli
provid
dr
gabriel
vielhab
symris
holzminden
germani
lipopolysaccharid
sigmaaldrich
ficz
obtain
enzo
life
scienc
plymouth
meet
pa
usa
proteas
inhibitor
roch
diagnost
tokyo
japan
also
purchas
antibodi
ahr
santa
cruz
biotechnolog
santa
cruz
ca
usa
santa
cruz
biotechnolog
thermo
fisher
scientif
waltham
usa
millipor
billerica
usa
cell
signal
technolog
inc
danver
usa
flag
sigmaaldrich
egfp
rabbit
antibodi
medic
biolog
laboratori
co
ltd
nagoya
japan
mous
monoclon
antibodi
abcam
cambridg
unit
kingdom
aquaporin
abcam
glyceraldehyd
dehydrogenas
gapdh
trevigen
gaithersburg
md
usa
use
primari
antibodi
rabbit
polyclon
antibodi
human
gener
use
peptid
mgkkqnrktgnsk
tqsac
amino
acid
denot
singl
letter
immunogen
medic
biolog
laboratori
alexa
fluor
antibodi
phalloidin
invitrogen
carlsbad
ca
usa
purchas
secondari
antibodi
igg
ge
healthcar
bioscienc
corp
piscataway
nj
usa
igg
ge
healthcar
igg
santa
cruz
biotechnolog
conjug
horseradish
peroxidas
use
immunohistochem
analysi
alexa
fluor
goat
igg
invitrogen
alexa
fluor
goat
igg
invitrogen
use
secondari
antibodi
hoechst
purchas
invitrogen
base
recent
report
rti
effici
block
use
potent
inhibitori
activ
less
effect
dna
polymeras
current
undergo
phase
iib
clinic
trial
patient
two
hour
inject
rvpr
inject
intraperiton
give
final
concentr
approxim
compound
transfer
blood
estim
volum
ml
purif
rvpr
assay
rvpr
express
use
escherichia
coli
purifi
describ
previous
figur
purifi
rvpr
test
endotoxin
use
highli
sensit
lipopolysaccharid
lp
assay
limulu
amebocyt
lysat
detect
limit
euml
wako
pure
chemic
ind
ltd
osaka
japan
assay
use
two
report
construct
r
semiquantit
quantit
pcr
coloni
format
assay
respect
construct
contain
compon
human
singl
transcript
unit
egfp
neo
r
insert
revers
orient
occur
intron
within
report
gene
splice
express
function
egfp
wherea
r
express
function
neomycinresist
gene
neo
r
cell
transfect
r
use
lipofectamin
invitrogen
xfect
takara
bio
inc
shiga
japan
cell
select
day
puromycin
puro
hygromycin
hygro
r
next
cell
treat
addit
day
indic
amount
rvpr
pcr
assay
genom
dna
prepar
harvest
cell
use
dna
extract
system
quickgen
fujifilm
tokyo
japan
semiquantit
pcr
primer
design
exon
would
amplifi
product
bp
wherea
would
gener
product
bp
upon
thu
occurr
determin
evalu
size
amplifi
product
stain
amplifi
dna
sybr
green
lonza
basel
switzerland
signal
intens
bp
band
measur
use
molecular
imag
fxpro
biorad
hercul
ca
usa
normal
signal
intens
band
use
intern
control
rel
intens
ri
bp
band
calcul
standard
signal
buffertr
sampl
qpcr
analysi
cgg
cat
caa
ggt
gaa
gtg
ttc
tgc
tgg
tag
design
exon
egfp
gene
use
forward
revers
primer
respect
taqmanprob
ag
c
tgg
ccg
ac
invitrogen
use
detect
amplicon
bp
length
denot
exon
junction
templat
dna
amplifi
eagl
taq
master
mix
roch
diagnost
cfx
connect
realtim
system
biorad
use
follow
amplif
condit
min
follow
cycl
sec
sec
obtain
standard
curv
egfpqpcr
egfp
dna
gener
induct
amplifi
use
primer
clone
pgemt
easi
vector
promega
madison
usa
confirm
nucleotid
sequenc
standard
sampl
prepar
mix
human
mous
genom
dna
egfpcontain
plasmid
give
copiescel
normal
amount
input
dna
human
mous
quantifi
qpcr
sybr
premix
ex
taq
takara
cfx
connect
realtim
system
biorad
human
forward
primer
gac
cca
gag
gtt
ctt
revers
primer
cca
ggc
cat
cac
taa
mous
forward
primer
cgt
tga
cat
ccg
taa
aga
revers
primer
ggt
gta
aaa
cgc
agc
coloni
format
assay
cell
transfect
r
select
hygro
cell
replat
new
plate
split
next
cell
treat
day
rvpr
cultur
presenc
neomycin
initi
experi
use
ngml
rvpr
maximum
report
plasma
vpr
concentr
patient
ngml
determin
vpr
activ
induct
six
plate
treat
rvpr
buffer
control
day
cultur
presenc
neomycin
week
cell
aggreg
stain
methylen
blue
coloni
enumer
minim
platetopl
variat
coloni
number
middl
four
six
plate
subject
statist
analysi
least
two
independ
experi
perform
repres
result
shown
effect
mab
vpr
induct
investig
appli
ng
rvpr
ng
give
approxim
excess
molar
amount
rvpr
min
incub
room
temperatur
reaction
mixtur
filtrat
ad
ml
cultur
medium
cell
control
sar
mab
irrelev
mab
recogn
spike
protein
sever
acut
respiratori
syndrom
corona
viru
sarscov
use
gene
two
small
interf
rna
sirna
prepar
appli
biosystem
foster
citi
ca
usa
thermo
scientif
function
evalu
transfect
cell
follow
wb
analysi
nucleotid
sequenc
sirna
shown
addit
file
tabl
evalu
inhibitori
effect
sirna
induct
sirna
introduc
day
initi
transfect
r
two
day
later
cell
replat
incub
day
rvpr
subject
analysi
silenc
neg
control
sirna
cat
life
technolog
corpor
carlsbad
ca
usa
use
control
cell
transfect
select
day
puro
day
transfect
cell
replat
subject
assay
examin
effect
mapk
inhibitor
concentr
respect
ad
h
addit
rvpr
cell
expos
ngml
rvpr
day
subject
qpcr
analysi
genom
dna
isol
use
quickgen
dna
tissu
kit
fujifilm
select
detect
egfp
gene
deriv
ng
dna
use
qpcr
templat
amplifi
gene
intern
control
ng
dna
use
qpcr
templat
vivo
experi
use
two
transgen
mous
line
fragment
introduc
transgen
mice
figur
sidebar
two
line
select
display
low
background
embryogenesi
respond
vigor
environment
compound
cpg
island
untransl
region
introduc
human
highli
methyl
mice
assess
pcrbase
assay
use
methylationspecif
primer
anim
experi
approv
anim
care
use
committe
nation
center
global
health
medicin
ncgm
fifteen
blood
sampl
obtain
antiretrovir
male
patient
present
ncgm
hospit
octob
octob
subject
pcrbase
assay
patient
year
age
viral
load
count
copiesml
cellsml
respect
nine
healthi
volunt
serv
control
detect
activ
cell
first
transfect
select
puro
heatinactiv
patient
serum
sampl
ad
ml
cultur
medium
cell
show
activ
patient
blood
attribut
vpr
serum
react
min
ng
sarss
mab
room
temperatur
reaction
volum
experiment
protocol
approv
institut
review
board
ncgm
la
mutant
contain
aqqaa
codon
wildtyp
wt
vpr
express
flagtag
protein
use
express
vector
sigmaaldrich
obtain
compar
level
express
protein
molar
ratio
plasmid
dna
wildtyp
vpr
la
mutant
transfect
respect
next
day
transfect
cell
subject
pcrbase
assay
use
tandem
affin
purif
construct
encod
chimer
protein
protein
calmodulinbind
protein
day
transfect
cell
ngml
rvpr
ad
cultur
medium
cell
extract
prepar
follow
day
chromatinenrich
fraction
chromatin
fraction
isol
use
subcellular
protein
fraction
kit
thermo
fisher
scientif
micrococc
nucleas
describ
previous
detect
perform
probe
horseradish
peroxidaseconjug
human
igg
jackson
immunoresearch
west
grove
pa
usa
use
intern
control
chromatin
fraction
cell
transfect
plasmid
construct
pflagvprwt
pflagvprla
mutant
pflagegfp
encod
flagtag
vpr
chimer
protein
egfp
flagtag
egfp
respect
day
transfect
cell
treat
ngml
rvpr
day
evalu
depend
proteinprotein
interact
vpr
cell
subject
ipwb
analysi
analyz
associ
cell
suspend
buffer
contain
mm
tri
ph
mm
nacl
mm
edta
proteas
inhibitor
cocktail
subject
brief
sonic
analysi
vprahr
associ
cell
suspend
buffer
contain
mm
hepe
ph
mm
nacl
glycerol
proteas
inhibitor
cocktail
complet
lyse
passag
g
g
needl
order
ten
time
cell
extract
preclear
protein
g
sepharos
bead
ge
healthcar
react
recov
protein
g
bead
input
sampl
extract
subject
immunoprecipit
assess
simultan
perfus
fixat
organ
immers
phosphat
buffer
pb
ph
supplement
paraformaldehyd
follow
day
sampl
serial
immers
pb
supplement
saccharos
h
saccharos
immers
complet
saccharos
overnight
next
sampl
embed
optim
cut
temperatur
compound
sakura
finetek
torranc
ca
usa
cryosect
use
cryostat
leica
biosystem
wetzlar
germani
three
slice
thick
prepar
differ
section
fix
kidney
first
slice
middl
part
kidney
second
section
part
contain
mainli
cortex
littl
amount
medulla
third
section
compos
mainli
cortex
sampl
wash
three
time
phosphatebuff
salin
pb
min
per
wash
incub
min
room
temperatur
imageit
fx
signal
enhanc
invitrogen
rins
three
time
mm
trishcl
ph
mm
nacl
tween
tbst
min
section
react
rabbit
antibodi
medic
biolog
laboratori
tbst
supplement
bovin
serum
albumin
bsa
follow
day
specimen
rins
three
time
tbst
incub
alexa
fluor
goat
igg
antibodi
invitrogen
h
room
temperatur
nuclear
dna
stain
hoechst
final
concentr
fluorolabel
section
examin
fluoresc
microscop
olympu
olympu
tokyo
japan
use
cellsen
system
olympu
total
cell
number
section
first
count
automat
next
number
egfpposit
cell
count
manual
frequenc
egfpposit
cell
calcul
use
number
total
egfpposit
cell
three
independ
section
prepar
singl
specimen
subject
analysi
signific
frequenc
egfpposit
cell
evalu
statist
identifi
rtec
posit
immunohistochemistri
perform
describ
previous
use
follow
primari
antibodi
antibodi
dilut
abcam
uk
antibodi
dilut
alexa
fluor
dilut
invitrogen
perform
sodium
bisulfit
treatment
genom
dna
use
ez
dna
methyl
kit
zymo
research
irvin
ca
usa
accord
manufactur
instruct
one
microlitr
aliquot
use
templat
combin
bisulfit
restrict
analysi
cobra
primer
use
amplif
transgen
promot
region
follow
forward
revers
pcr
reaction
perform
volum
contain
bisulfitetr
genom
dna
primer
epitect
msp
kit
qiagen
hilden
germani
amplif
condit
consist
cycl
sec
sec
sec
pcr
product
digest
use
restrict
enzym
taq
new
england
biolab
ipswich
usa
specif
methyl
sequenc
sodium
bisulfit
treatment
digest
product
resolv
agaros
gel
electrophoresi
stain
ethidium
bromid
statist
signific
evalu
use
mannwhitney
utest
p
valu
deem
indic
statist
signific
